XML 44 R23.htm IDEA: XBRL DOCUMENT
v3.25.1

Share-Based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Compensation |
Share-Based Compensation | 17.Share-Based Compensation A summary of share-based compensation expense recognized related to share options granted, RSUs granted, and ordinary shares transfers is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year ended December 31,
​ |  | 2022 |  | 2023 |  | 2024
​ | ​ | RMB | ​ | RMB | ​ | RMB
Sales and marketing expenses | ​ | 16,120 | ​ | 35,352 | ​ | 6,825
General and administrative expenses | ​ | 80,448 | ​ | 85,335 | ​ | 69,245
Research and development expenses | ​ | 15,458 | ​ | 13,182 | ​ | 10,802
​ | ​ | 112,026 | ​ | 133,869 | ​ | 86,872
​ As of December 31, 2024, unrecognized compensation cost related to unvested RSUs granted, share option awards granted to employees of the Group was RMB91,593. As of December 31, 2024, such cost was expected to be recognized over a weighted average period of 1.2 years. Share Option granted by the Company In 2019, the Group adopted the 2018 share incentive plan (the “2018 Plan”), which permits the grant of three types of awards: options, restricted shares, and restricted share units. Persons eligible to participate in the 2018 Plan includes employees (including members of management) of the Company, the Company’s parent companies and subsidiaries. Upon the adoption of the 2018 Plan, the maximum ordinary shares available for issuance were 62,504,000. According to the resolutions of the board of director in 2019, the Group reserved additional 321,655,746 ordinary shares for the 2018 Plan, and the maximum ordinary shares available for issuance were increased to 384,159,746. ​
17. | Share-Based Compensation (continued)
Share Option granted by the Company (continued) During the year ended December 31, 2023, the Group granted 281,250 options under the 2018 Plan with a weighted average exercise prices of US$0.08 (RMB0.57). During the year ended December 31, 2024, there are no options granted under the 2018 Plan. The term of the option is fixed and does not exceed 10 years from the date of the grant. The options will vest in accordance with the vesting schedules set out in the respective share option agreements with vesting period ranging from 1 to 4 years. In 2021, the Group adopted the 2021 share incentive plan (the “2021 Plan”), the maximum aggregate number of shares which may be issued pursuant to all awards under the 2021 Plan shall initially be 80,508,501 shares, plus an annual increase on the first day of each year during the ten-year term of the 2021 Plan commencing with the year beginning January 1, 2022, by an amount equal to the lesser of (i) 2% of the total number of shares issued and outstanding on an as-converted fully diluted basis on the last day of the immediately preceding year and (ii) such number of shares as may be determined by the board. The annual increase shall cease to occur upon expiry of the ten-year term of the 2021 Plan. There are no options granted under the 2021 Plan as of December 31, 2024. The vesting of the share options granted during the years ended December 31, 2023 and 2024 are only subject to service condition. The following table sets forth the share options activities under the 2018 Plan for the years ended December 31, 2022, 2023 and 2024: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ |  | Weighted |  | Weighted |  | ​
​ | ​ | ​ | ​ | Weighted | ​ | Average | ​ | Average | ​ | ​
​ | ​ | ​ | ​ | Average | ​ | remaining | ​ | Grant- | ​ | Aggregate
​ | ​ | Number of | ​ | Exercise | ​ | contractual | ​ | date Fair | ​ | Intrinsic
​ | ​ | Options | ​ | Price | ​ | life | ​ | Value | ​ | Value
​ |  | ​ |  | RMB |  | RMB |  | RMB |  | RMB
Outstanding as of December 31, 2021 | ​ | 247,008,342 | ​ | 0.29 | ​ | 7.94 | ​ | 2.10 | ​ | 543,248
Granted |  | 800,000 | ​ | 0.54 | ​ | — | ​ | 0.70 | ​ | —
Exercised |  | (27,750,770) | ​ | 0.39 | ​ | — | ​ | 1.20 | ​ | —
Forfeited |  | (30,645,015) | ​ | 0.31 | ​ | — | ​ | 3.52 | ​ | —
Outstanding as of December 31, 2022 | ​ | 189,412,557 | ​ | 0.28 | ​ | 6.95 | ​ | 2.14 | ​ | 452,543
Granted | ​ | 281,250 | ​ | 0.57 | ​ | — | ​ | 0.57 | ​ | —
Exercised | ​ | (72,294,940) | ​ | 0.14 | ​ | — | ​ | 1.52 | ​ | —
Forfeited | ​ | (11,127,905) | ​ | 0.46 | ​ | — | ​ | 4.11 | ​ | —
Outstanding as of December 31, 2023 |  | 106,270,962 | ​ | 0.36 | ​ | 6.19 | ​ | 2.56 | ​ | 276,835
Exercised |  | (16,036,480) | ​ | 0.47 | ​ | — | ​ | 2.53 | ​ | —
Forfeited |  | (3,312,540) | ​ | 0.57 | ​ | — | ​ | 4.18 | ​ | —
Outstanding as of December 31, 2024 |  | 86,921,942 | ​ | 0.37 | ​ | 5.19 | ​ | 2.55 | ​ | 226,780
Exercisable as of December 31, 2024 |  | 79,366,900 | ​ | 0.35 | ​ | 5.09 | ​ | 2.29 | ​ | 186,936
​ The total intrinsic value of options exercised during the years ended December 31, 2023 and 2024 was RMB112,499 and RMB6,190, respectively. ​
17. | Share-Based Compensation (continued)
Share Option granted by the Company (continued) The Group calculated the estimated fair value of the share options on the respective grant dates using the binomial option pricing model with the assistance from an independent valuation firm, with the following assumptions. ​
​ | ​ | ​ | ​ | ​
​ |  | Year Ended |
​ | ​ | December 31 | ​
​ | ​ | 2023 | ​
Risk free rate of interest |  | ​ | 2.55%‑2.94 | %
Volatility |  | ​ | 28 | %
Dividend yield |  | ​ | — |
Exercise multiples |  | ​ | 2.2 |
Life of options (years) |  | ​ | 10 |
Fair value of underlying ordinary shares | ​ | $ | 0.11~$0.29 | ​
​
(1) | Risk free rate of interest
Based on the daily treasury long term rate of U.S. Department of the treasury with a maturity period close to the expected term of the option.
(2) | Volatility
The volatility factor estimated was based on the annualized standard deviation of the daily return embedded in historical share prices of the selected guideline companies with a time horizon close to the expected expiry of the term.
(3) | Dividend yield
The Company had never declared or paid any cash dividends on the Company’s ordinary shares as of December 31, 2023.
(4) | Exercise multiples
The expected exercise multiple was estimated as the average ratio of the stock price as at the time when employees would decide to voluntarily exercise their vested options. As the Group did not have sufficient information of past employee exercise history, it was estimated by referencing to academic research publications.
(5) | Fair value of underlying ordinary shares
The estimated fair value of the ordinary shares underlying the options as of the respective grant dates was determined based on market value of the Company’s shares on each date of grant. ​
17. | Share-Based Compensation (continued)
Restricted share units(“RSUs”) granted by the Company During the year ended December 31, 2023 and 2024, the Group granted 69,910,980 and 22,140,000 restricted share units to certain employees and senior management under the 2018 Plan, which vest over 1 to 4 years. The estimated fair value of each RSU granted is based on market value of the Company’s shares on each date of grant. A summary of the RSUs activities under the 2018 Plan for the year ended December 31, 2022, 2023 and 2024 is presented as follow: ​
​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted Average
​ | ​ | ​ | ​ | Grant-date
​ | ​ | Number of RSUs | ​ | Fair Value
​ |  | ​ |  | RMB
As of January 1, 2022 |  | — |  | —
Granted |  | 112,336,970 |  | 0.83
Vested |  | (10,141,620) |  | 0.74
Forfeited or cancelled |  | (425,000) |  | 0.75
As of December 31, 2022 | ​ | 101,770,350 |  | 0.84
Granted | ​ | 69,910,980 | ​ | 1.41
Vested | ​ | (22,617,630) | ​ | 0.91
Forfeited or cancelled | ​ | (44,548,350) | ​ | 0.94
Unvested as of December 31, 2023 | ​ | 104,515,350 | ​ | 1.22
Granted | ​ | 22,140,000 | ​ | 0.78
Vested | ​ | (30,681,250) | ​ | 1.14
Forfeited or cancelled | ​ | (23,152,890) | ​ | 1.44
Unvested as of December 31, 2024 |  | 72,821,210 |  | 1.08
​ During the year ended December 31, 2024, the Group granted 48,636,040 restricted share units to certain employees and senior management under the 2021 Plan, which vest over 1 to 4 years. The estimated fair value of each RSU granted is based on market value of the Company’s shares on each date of grant. A summary of the RSUs activities under the 2021 Plan for the year ended December 31, 2024 is presented as follow: ​
​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted Average
​ | ​ | ​ | ​ | Grant-date
​ |  | Number of RSUs |  | Fair Value
​ | ​ | ​ | ​ | RMB
As of January 1, 2024 | ​ | — | ​ | —
Granted | ​ | 48,636,040 | ​ | 0.83
Vested |  | — |  | —
Forfeited or cancelled |  | (2,000,000) |  | 0.84
Unvested as of December 31, 2024 |  | 46,636,040 |  | 0.83
​ The total fair value of RSU vested during the years ended December 31, 2023 and 2024 was RMB31,872 and RMB26,798, respectively. ​ 17.Share-Based Compensation (continued) Share Option granted by Shenlanbao Shenlanbao has the following active share incentive plans: 2019 SLB share incentive plan,2020 SLB share incentive plan, 2021 SLB share incentive plan and 2022 SLB share incentive plan (collectively referred to as the “SLB plans”). The SLB plans permit the grant of option to the directors and employees to purchase Shenlanbao’s shares. Pursuant to the above plan, a maximum aggregate of 1,000,000 registered capital of Shenlanbao may be issued. The term of the option is fixed and does not exceed 5 years from the date of the grant. The options will vest ratably over a 4-year vesting period from the grant date and are only subject to service condition. In September 2023, the board of Shenlanbao approved the amended and restated SLB plan (the “New SLB Plan”), which adjusted the number of shares to a maximum aggregate of 577,121 registered capital. The New SLB Plan also reduced the exercise price of the option and extended the term of option to 10 years. The Group accounted for the reduction of the exercise price of the options as a modification which requires the re-measurement of the fair value of these share options. This remeasurement resulted in a total incremental share-based compensation of RMB4,794, RMB2,018 of which is recognized on the modification date in 2023, and the remaining will be amortized through the vesting period of the option. During the year ended December 31, 2024, there are no options granted under the New SLB Plan. The following table summarizes the option activity for the year ended December 31, 2023 and 2024: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ |  | Weighted |  | Weighted |  |
​ | ​ | ​ | ​ | Weighted | ​ | Average | ​ | Average | ​ | ​
​ | ​ | ​ | ​ | Average | ​ | remaining | ​ | Grant- | ​ | Aggregate
​ | ​ | Number of | ​ | Exercise | ​ | contractual | ​ | date Fair | ​ | Intrinsic
​ | ​ | Options | ​ | Price | ​ | life | ​ | Value | ​ | Value
​ | ​ | ​ |  | RMB |  | RMB |  | RMB |  | RMB
Outstanding as of the acquisition date |  | 450,246 | ​ | 15.90 | ​ | 7.68 | ​ | 24.81 | ​ | 7,162
Forfeited |  | (19,438) | ​ | 23.57 | ​ | — | ​ | 21.41 | ​ | —
Outstanding as of December 31, 2023 |  | 430,808 | ​ | 15.55 | ​ | 7.69 | ​ | 24.96 | ​ | 6,921
Forfeited |  | (91,563) | ​ | 15.48 | ​ | — | ​ | 28.84 | ​ | —
Outstanding as of December 31, 2024 |  | 339,245 | ​ | 16.01 | ​ | 6.54 | ​ | 23.91 | ​ | 5,266
Exercisable as of December 31, 2024 |  | 291,402 | ​ | 16.21 | ​ | 6.37 | ​ | 22.63 | ​ | 3,848
​ The Group calculated the estimated fair value of the share options on the respective grant dates using the binomial option pricing model with the assistance from an independent valuation firm, with the following assumptions. ​
​ | ​ | ​ | ​
​ |  | Year Ended December 31 |
​ | ​ | 2023 |
Risk free rate of interest |  | 2.64%-3.01 | %
Volatility |  | 29.8%-44.2 | %
Dividend yield |  | — | ​
Exercise multiples |  | 2.2-2.8 | ​
Life of options (years) |  | 10 | ​
Fair value of underlying ordinary shares |  | 13.37~36.29 | ​
​ ​

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration